Introduction
'Incorrect test results are much more often due to patient and specimen collection considerations than to laboratory variability or error' [1] , according to one USA based professional organization. Shapiro [2] noted in a study involving thousands of patients, more than 5% of the individually collected specimens were questionable based on pre-analytical error, and, indeed, more than 15% of the specimens received from the emergency room were associated with significant pre-analytical error! Since 'blood gas and pH analysis has more immediacy and potential impact on patient care than any other laboratory determination' [3] , it is evident that while the medical laboratory analyst must be primarily aware of the impact of analytical error, pre-analytical considerations need to be taken into account by others in the assessment of the reliability of results to be reported. An understanding by physicians, nurses and other direct patient care practitioners of the 'Cycle of quality assurance' (see figure) for blood gases and other critical analytes will minimize the chances that pre-analytical error will significantly effect patient care. The laboratory professional must be involved in the process of education about these issues.
Pre-analytical considerations
Of major impact on the utility of blood gas, total haemoglobin and electrolyte results are (1) the physiologic stability of the patient; (2) [6] . Some data indicates that samples from patients with cold agglutinins may be substantially elevated after only a few (<15) minutes in the ice-water slurry [7] . Both As noted earlier, many or even most blood gas result 'errors' occur outside the area of laboratory analysis [1, 2] . Additionally, many modern blood gas analysers incorporate automatic devices which signal when the analyser is not performing adequately.
Despite these facts, there is an increasing level of activity in the use ofinternal and external quality control schemes to check on analyser performance. Quality control schemes, of course, only check on performance of the analyser on the test material actually chosen, and at the time the control material is actually measured. As such, any such quality control scheme needs to be considered as only a part of a complete programme that addresses the various issues discussed in this report. The requirements and complications of quality control protocols for a blood gas analyser are substantially different from other analyses performed in the clinical laboratory environment. This is due substantially to the combination of turnaround time requirements for the patient sample, the fact that the patient sample is fresh whole blood--that is--living tissue, and of course, the various pre-analytical items discussed earlier in this report.
The optimum technique for establishing the inaccuracy and imprecision of the gas channels ofan individual blood gas analyser is the use of whole blood tonometry [11, 12] [3, 13] [13] and comparing results with specific performance problems, an overall scheme can be developed. If done in this planned, stepwise manner, it will best meet the particular institution's requirements by balancing costs, time, and quality.
Summary
As indicated at the outset of this article, the critical nature of the clinical requirements when blood gas testing is indicated, coupled with the labile nature of the sample and rapidly changing patient conditions, makes it imperative that the analyst be aware of more than just the analysis itself. Knowledge by the analyst of the effects of the changing patient environment, and the manner in which the sample is treated in the few short minutes from collection to reporting are equally important if one is to assure timely and clinically meaningful results.
